Ebitda Endring Dato
Agilent USD 456M 18M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Bruker USD 168.8M 7.1M 2023-12
Catalent USD 22M 52M 2023-12
Centene USD 1.53B 90.5M 2023-09
Charles River Laboratories USD 230.82M 15.75M 2023-12
Cigna USD 3.01B 30M 2023-09
Danaher USD 1.83B 126M 2023-12
Dentsply International USD 158M 8M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Hologic USD 315.1M 50.8M 2023-12
Illumina USD -10000000 242M 2023-12
Intuitive Surgical USD 455.3M 134.9M 2023-12
IQVIA Holdings USD 924M 116M 2023-12
J&J USD 6.46B 1.51B 2023-12
Laboratory Of America USD 462.1M 46.2M 2023-12
Lonza CHF 922M 285M 2023-06
McKesson USD 1.06B 256M 2023-09
Merck EUR 1.47B 125M 2023-09
Merck USD 7.51B 11.02B 2023-09
Mettler Toledo International USD 295.89M 13.44M 2023-12
Pfizer USD 1.14B 2.05B 2023-12
Quest Diagnostics USD 387M 72M 2023-12
Repligen USD 26.62M 25.06M 2023-12
Revvity USD 207.71M 6.39M 2023-12
Roche Holding CHF 12.35B 1.92B 2023-06
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12
Thermo Fisher Scientific USD 2.79B 12M 2023-12
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 227.49M 11.13M 2023-09
West Pharmaceutical Services USD 194.7M 23.1M 2023-12



Catalent - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.